The fight against AIDS, TB, and malaria is at risk. Global health financing faces severe cuts. This threatens decades of progress. Urgent calls are being made for Global Fund replenishment. Without it, countless lives are in danger. Médecins Sans Frontières (MSF) has sounded an alarm. The medical group has released a new report. It is titled Deadly Gaps. The report…
Tag: Global Fund
-
HIV Prevention Injection Changes the Game in Treatment
South Africa will introduce a new lenacapavir injection. This twice-yearly shot is for HIV prevention. It will be in select public clinics by April 2026. This marks a big step forward for the nation. It offers a great alternative to daily pills. However, another injectable, cabotegravir, is stalled. It had a four-year head start. The availability of a new HIV…
-
HIV Prevention Injection Changes the Game in Treatment
South Africa will introduce a groundbreaking twice-yearly HIV prevention injection, lenacapavir, in select public clinics by April 2026. This move marks a significant step forward in the nation’s fight against HIV, offering a highly effective and convenient alternative to daily pills. However, this progress comes as another long-acting injectable, cabotegravir (CAB-LA), remains stalled despite having a four-year head start. The…
-
Sakeliga’s NHI Legal Battle for Constiutional Justice
Sakeliga’s NHI Legal Battle has garnered attention. The business lobby group Sakeliga has become the latest organisation to mount a legal challenge against South Africa’s contentious National Health Insurance (NHI) Act. They filed papers at the Pretoria High Court to have it declared unconstitutional and invalid. The focus of Sakeliga’s NHI Legal Battle is to highlight the impracticalities and financial…
-
Lenacapavir for HIV Prevention in South Africa
South Africa is taking a giant step in its fight against HIV. The Department of Health announced plans to make a new, twice-yearly anti-HIV injection available in public clinics. The drug, lenacapavir, represents a potential turning point for HIV prevention. It could significantly curb new infections across the nation. Introducing lenacapavir for HIV prevention could change the landscape of health…
-
HIV/AIDS Funding Gap: Government Steps In
The South African government has stepped in with a crucial R753.5 million injection from the National Treasury to sustain the nation’s HIV/Aids programmes. This vital funding seeks to close the HIV/AIDS funding gap. The withdrawal of the United States President’s Emergency Plan for AIDS Relief (PEPFAR) significantly impacted this gap. This move had threatened to derail decades of progress in…
-
Global Health Giants Consider Merger Amidst Funding Crunch
In a significant development for global health, two of the world’s leading organisations, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Gavi vaccine alliance, are in discussions to merge some operational functions. This strategic move aims to combat a severe financing crunch. A Response to Aid Budget Pull-Backs While discussions about more efficient collaboration have been ongoing…
-
HIV/AIDS Programme Remains Strong Amid Funding Cuts
Health Minister Aaron Motsoaledi has provided reassurances on the future of South Africa’s HIV/Aids programme following the withdrawal of PEPFAR funding. He detailed the government’s mitigation efforts and engagements with potential donors.1 HIV/AIDS Programme ‘Not at Risk of Collapsing’ Health Minister Aaron Motsoaledi has moved to quell fears surrounding the future of South Africa’s HIV/Aids response. He firmly stated the…
-
SA confident of HIV treatment goals despite aid cuts
Health Minister Aaron Motsoaledi has reassured Parliament that he is confident in achieving its ambitious HIV treatment targets despite recent cuts in US aid. The minister’s assurance comes as a response to concerns raised by MPs regarding the potential impact of US funding reductions on South Africa’s healthcare system. South Africa aims to provide treatment to an additional 1.1 million…
-
Global fund affirms commitment to lenacapavir rollout
The Global Fund for HIV, TB, and Malaria has reaffirmed its commitment to rolling out the twice-yearly HIV prevention jab, lenacapavir, in lower-income countries, including South Africa. This initiative will continue with or without the support of the US President’s Emergency Plan for AIDS Relief (Pepfar), which recently encountered funding disruptions during President Donald Trump’s term. According to Global Fund…